My Quality Solutions

Megamix Line: Expand the limits of MP analysis with 2 new products

In addition to functional assays currently available at Stago (STA®-Procoag PPL and CAT) Megamix products are two new tools designed for standardising Microparticle (MP) quantitative analysis by flow cytometry. These products assist in the process of setting-up a standardised MP gate to ensure a good inter-instrument and inter-lab reproducibility. They are also used as a day-to-day QC to check instrument consistency.

STA Compact Max®: Innovation born from Expertise

STA Compact Max® is the new generation of analyser developed by the Coagulation Company to meet labs' expectations.

STA®-ImmunoDef VIII & STA®-ImmunoDef IX

As part of Stago's continuous improvement commitment, STA®-ImmunoDef VIII* & STA®-ImmunoDef IX* kits have been developed as a new generation of Deficient Plasmas with enhanced performance. Factors VIII and IX measurement allows characterising clinically significant conditions such as Haemophilia A and B. Robust and reliable reagents should be available for an easier daily laboratory practice.

New range of STA®-Routine QC quality control plasmas: The best range for routine laboratory tests

To fulfil regulatory requirements, laboratories must perform regular internal quality control (IQC) on at least two concentration levels (normal and abnormal) to check and confirm the performance of their testing systems.

STA®-Rivaroxaban Calibrator & STA®-Rivaroxaban Control

Rivaroxaban is an oral anticoagulant, direct factor Xa inhibitor, developed by Bayer HealthCare and sold under the trade name Xarelto®. It is approved in three indications in Europe: prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors, treatment of deep vein thrombosis (DVT) and prevention of recurrent DVT and pulmonary embolism (PE) following an acute DVT in adults and prevention of VTE in adult patients undergoing elective hip or knee replacement surgery.